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Abstract
BACKGROUND—Despite the imminent expansion of Medicaid coverage for low-income adults,
the effects of expanding coverage are unclear. The 2008 Medicaid expansion in Oregon based on
lottery drawings from a waiting list provided an opportunity to evaluate these effects.
METHODS—Approximately 2 years after the lottery, we obtained data from 6387 adults who
were randomly selected to be able to apply for Medicaid coverage and 5842 adults who were not
selected. Measures included blood-pressure, cholesterol, and glycated hemoglobin levels;
screening for depression; medication inventories; and self-reported diagnoses, health status, health
care utilization, and out-of-pocket spending for such services. We used the random assignment in
the lottery to calculate the effect of Medicaid coverage.
RESULTS—We found no significant effect of Medicaid coverage on the prevalence or diagnosis
of hypertension or high cholesterol levels or on the use of medication for these conditions.
Medicaid coverage significantly increased the probability of a diagnosis of diabetes and the use of
diabetes medication, but we observed no significant effect on average glycated hemoglobin levels
or on the percentage of participants with levels of 6.5% or higher. Medicaid coverage decreased
the probability of a positive screening for depression (−9.15 percentage points; 95% confidence
interval, −16.70 to −1.60; P = 0.02), increased the use of many preventive services, and nearly
eliminated catastrophic out-of-pocket medical expenditures.
CONCLUSIONS—This randomized, controlled study showed that Medicaid coverage generated
no significant improvements in measured physical health outcomes in the first 2 years, but it did
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increase use of health care services, raise rates of diabetes detection and management, lower rates
of depression, and reduce financial strain.
In 2008, oregon initiated a limited expansion of its medicaid program for low- income adults
through a lottery drawing of approximately 30,000 names from a waiting list of almost
90,000 persons. Selected adults won the opportunity to apply for Medicaid and to enroll if
they met eligibility requirements. This lottery presented an opportunity to study the effects
of Medicaid with the use of random assignment. Earlier, nonrandomized studies sought to
investigate the effect of Medicaid on health outcomes in adults with the use of quasi-
experimental approaches.1–3 Although these approaches can be an improvement over
observational designs and often involve larger samples than are feasible with a randomized
design, they cannot eliminate confounding factors as effectively as random assignment. We
used the random assignment embedded in the Oregon Medicaid lottery to examine the
effects of insurance coverage on health care use and health outcomes after approximately 2
years.
METHODS
RANDOMIZATION AND INTERVENTION
Oregon Health Plan Standard is a Medicaid program for low-income, uninsured, able-bodied
adults who are not eligible for other public insurance in Oregon (e.g., Medicare for persons
65 years of age or older and for disabled persons; the Children’s Health Insurance Program
for poor children; or Medicaid for poor children, pregnant women, or other specific,
categorically eligible populations). Oregon Health Plan Standard closed to new enrollment
in 2004, but the state opened a new waiting list in early 2008 and then conducted eight
random lottery drawings from the list between March and September of that year to allocate
a limited number of spots.
Persons who were selected won the opportunity — for themselves and any household
member — to apply for Oregon Health Plan Standard. To be eligible, persons had to be 19
to 64 years of age and Oregon residents who were U.S. citizens or legal immigrants; they
had to be ineligible for other public insurance and uninsured for the previous 6 months, with
an income that was below 100% of the federal poverty level and assets of less than $2,000.
Persons who were randomly selected in the lottery were sent an application. Those who
completed it and met the eligibility criteria were enrolled in the plan. Oregon Health Plan
Standard provides comprehensive medical benefits, including prescription drugs, with no
patient cost-sharing and low monthly premiums ($0 to $20, based on income), mostly
through managed-care organizations. The lottery process and Oregon Health Plan Standard
are described in more detail elsewhere.4
DATA COLLECTION
We used an in-person data-collection protocol to assess a wide variety of outcomes. We
limited data collection to the Portland, Oregon, metropolitan area because of logistical
constraints. Our study population included 20,745 people: 10,405 selected in the lottery (the
lottery winners) and 10,340 not selected (the control group). We conducted interviews
between September 2009 and December 2010. The interviews took place an average of 25
months after the lottery began.
Our data-collection protocol included detailed questionnaires on health care, health status,
and insurance coverage; an inventory of medications; and performance of anthropometric
and blood-pressure measurements. Dried blood spots were also obtained.5 Depression was
assessed with the use of the eight-question version of the Patient Health Questionnaire
(PHQ-8),6 and self-reported health-related quality of life was assessed with the use of the
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Medical Outcomes Study 8-Item Short-Form Survey.7 More information on recruitment and
field-collection protocols are included in the study protocol (available with the full text of
this article at NEJM.org); more information on specific outcome measures is provided in the
Supplementary Appendix (available at NEJM.org). Multiple institutional review boards
approved the study, and written informed consent was obtained from all participants.
STATISTICAL ANALYSIS
Virtually all the analyses reported here were pre-specified and publicly archived (see the
protocol).8 Prespecification was designed to minimize issues of data and specification
mining and to provide a record of the full set of planned analyses. The results of a few
additional post hoc analyses are also presented and are noted as such in Tables 1 through 5.
Analyses were performed with the use of Stata software, version 12.9
Adults randomly selected in the lottery were given the option to apply for Medicaid, but not
all persons selected by the lottery enrolled in Medicaid (either because they did not apply or
because they were deemed ineligible). Lottery selection increased the probability of
Medicaid coverage during our study period by 24.1 percentage points (95% confidence
interval [CI], 22.3 to 25.9; P<0.001). The subgroup of lottery winners who ultimately
enrolled in Medicaid was not comparable to the overall group of persons who did not win
the lottery. We therefore used a standard instrumental-variable approach (in which lottery
selection was the instrument for Medicaid coverage) to estimate the causal effect of
enrollment in Medicaid. Intuitively, since the lottery increased the chance of being enrolled
in Medicaid by about 25 percentage points, and we assumed that the lottery affected
outcomes only by changing Medicaid enrollment, the effect of being enrolled in Medicaid
was simply about 4 times (i.e., 1 divided by 0.25) as high as the effect of being able to apply
for Medicaid. This yielded a causal estimate of the effect of insurance coverage.10 (See the
Supplementary Appendix for additional details.)
All analyses were adjusted for the number of household members on the lottery list because
selection was random, conditional on household size. Standard errors were clustered
according to household to account for intrahousehold correlation. We fitted linear
probability models for binary outcomes. As sensitivity checks, we showed that our results
were robust when the average marginal effects from logistic regressions for binary outcomes
were estimated and when demographic characteristics were included as covariates (see the
Supplementary Appendix). All analyses were weighted for the sampling and field-collection
design; construction of the weights is detailed in the Supplementary Appendix.
RESULTS
STUDY POPULATION
Characteristics of the respondents are shown in Table 1. A total of 12,229 persons in the
study sample responded to the survey, for an effective response rate of 73%. There were no
significant differences between those selected in the lottery and those not selected with
respect to the response rates to either the full survey (0.28 percentage points higher in the
group selected in the lottery, P = 0.86) or specific survey measures, each of which had a
response rate of at least 97% among people who completed any part of the survey. Just over
half the participants were women, about a quarter were 50 to 64 years of age (the oldest
eligible age group), and about 70% were non-Hispanic white. There were no significant
differences between those selected in the lottery and those not selected with respect to these
characteristics (F statistic, 0.20; P = 0.99) or to the wide variety of prerandomization and
interview characteristics examined (see the Supplementary Appendix).
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CLINICAL MEASURES AND HEALTH OUTCOMES
Table 2 shows estimated effects of Medicaid coverage on blood-pressure, total and high-
density lipoprotein (HDL) cholesterol, and glycated hemoglobin levels and depression. In
the control group, 30% of the survey respondents had positive screening results for
depression, and we detected elevated blood pressure in 16%, a high total cholesterol level in
14%, and a glycated hemoglobin level of 6.5% or more (a diagnostic criterion for diabetes)
in 5%. Medicaid coverage did not have a significant effect on measures of blood pressure,
cholesterol, or glycated hemoglobin. Further analyses involving two prespecified subgroups
— persons 50 to 64 years of age and those who reported receiving a diagnosis of diabetes,
hypertension, a high cholesterol level, a heart attack, or congestive heart failure before the
lottery (all of which were balanced across the two study groups) — showed similar results
(see the Supplementary Appendix).
The predicted 10-year risk of cardiovascular events was measured with the use of the
Framingham risk score, which estimates risk among persons older than 30 years of age
according to sex, age, levels of total cholesterol and HDL cholesterol, blood pressure and
use or nonuse of blood-pressure medication, status with respect to diabetes, and smoking
status, with the predicted risk of a cardiovascular event within 10 years ranging from less
than 1% to 30%.11 The 10-year predicted risk did not change significantly with Medicaid
coverage (−0.21 percentage points; 95% CI, −1.56 to 1.15; P = 0.76).
We investigated whether Medicaid coverage affected the diagnosis of and use of medication
for hypertension, hypercholesterolemia, or diabetes. Table 2 shows diagnoses after the
lottery and current medication use. We found no effect of Medicaid coverage on diagnoses
after the lottery or on the use of medication for blood-pressure and high cholesterol levels.
We did, however, find a greater probability of receiving a diagnosis of diabetes (3.83
percentage points; 95% CI, 1.93 to 5.73; P<0.001) and using medications for diabetes (5.43
percentage points; 95% CI, 1.39 to 9.48; P=0.008). These are substantial increases from the
mean rates of diagnosis and medication use in the control group (1.1% and 6.4%,
respectively).
A positive result on screening for depression was defined as a score of 10 or more on the
PHQ-8 (which ranges from 0 to 24, with higher scores indicating more symptoms of
depression). Medicaid coverage resulted in an absolute decrease in the rate of depression of
9.15 percentage points (95% CI, −16.7 to −1.60; P = 0.02), representing a relative reduction
of 30%. Although there was no significant increase in the use of medication for depression,
Medicaid coverage led to an absolute increase in the probability of receiving a diagnosis of
depression after the lottery of 3.81 percentage points (95% CI, 0.15 to 7.46; P = 0.04),
representing a relative increase of about 80%.
HEALTH-RELATED QUALITY OF LIFE AND HAPPINESS
Table 3 shows the effects of Medicaid coverage on health-related quality of life and level of
happiness. Medicaid coverage led to an increase in the proportion of people who reported
that their health was the same or better as compared with their health 1 year previously (7.84
percentage points; 95% CI, 1.45 to 14.23; P = 0.02). The physical-component and mental-
component scores of the health-related quality of life measure are based on different
weighted combinations of the eight-question battery; each ranges from 0 to 100, with higher
scores corresponding to better health-related quality of life. Medicaid coverage led to an
increase of 1.95 points (95% CI, 0.03 to 3.88; P = 0.05) in the average score on the mental
component; the magnitude of improvement was approximately one fifth of the standard
deviation of the mental-component score. We did not detect a significant difference in the
quality of life related to physical health or in self-reported levels of pain or happiness.
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FINANCIAL HARDSHIP
Table 4 shows that Medicaid coverage led to a reduction in financial strain from medical
costs, according to a number of self-reported measures. In particular, catastrophic
expenditures, defined as out-of-pocket medical expenses exceeding 30% of income, were
nearly eliminated. These expenditures decreased by 4.48 percentage points (95% CI, −8.26
to −0.69; P = 0.02), a relative reduction of more than 80%.
ADDITIONAL OUTCOMES
Table 5 shows the effects of Medicaid coverage on health care utilization, spending on
health care, preventive care, access to and quality of care, smoking status, and obesity.
Medicaid coverage resulted in an increase in the number of prescription drugs received and
office visits made in the previous year; we did not find significant changes in visits to the
emergency department or hospital admissions. We estimated that Medicaid coverage
increased annual medical spending (based on measured use of prescription drugs, office
visits, visits to the emergency department, and hospital admissions) by $1,172, or about 35%
relative to the spending in the control group. Medicaid coverage also led to increases in
some preventive care and screening services, including cholesterol screening (an increase of
14.57 percentage points; 95% CI, 7.09 to 22.04; P<0.001) and improved perceived access to
care, including a usual place of care (an increase of 23.75 percentage points; 95% CI, 15.44
to 32.06; P<0.001). We found no significant effect of Medicaid coverage on the probability
that a person was a smoker or obese.
DISCUSSION
This study was based on more than 12,000 in-person interviews conducted approximately 2
years after a lottery that randomly assigned access to Medicaid for low-income, able-bodied,
uninsured adults — a group that comprises the majority of persons who are newly eligible
for Medicaid under the 2014 expansion.12 The results confirm that Medicaid coverage
increased overall health care utilization, improved self-reported health, and reduced
financial strain; these findings are consistent with previously published results based on mail
surveys conducted approximately 1 year after the lottery.4 With these new data, we found
that increased health care utilization observed at 1 year persisted, and we present new results
on the effects of Medicaid coverage on objectively measured physical health, depression,
condition-specific treatments, and other outcomes of interest.
Medicaid coverage had no significant effect on the prevalence or diagnosis of hypertension
or high cholesterol levels or on the use of medication for these conditions. It increased the
probability of a diagnosis of diabetes and the use of medication for diabetes, but it had no
significant effect on the prevalence of measured glycated hemoglobin levels of 6.5% or
higher. Medicaid coverage led to a substantial reduction in the risk of a positive screening
result for depression. This pattern of findings with respect to clinically measured health —
an improvement in mental health but not in physical health (Table 2) — was mirrored in the
self-reported health measures, with improvements concentrated in mental rather than
physical health (Table 3). The improvements appear to be specific to depression and mental
health measures; Medicaid coverage did not appear to lead to an increase in self-reported
happiness, which is arguably a more general measure of overall subjective well-being.
Hypertension, high cholesterol levels, diabetes, and depression are only a subgroup of the
set of health outcomes potentially affected by Medicaid coverage. We chose these
conditions because they are important contributors to morbidity and mortality, feasible to
measure, prevalent in the low-income population in our study, and plausibly modifiable by
effective treatment within a 2-year time frame.13–16 Nonetheless, our power to detect
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changes in health was limited by the relatively small numbers of patients with these
conditions; indeed, the only condition in which we detected improvements was depression,
which was by far the most prevalent of the four conditions examined. The 95% confidence
intervals for many of the estimates of effects on individual physical health measures were
wide enough to include changes that would be considered clinically significant — such as a
7.16-percentage-point reduction in the prevalence of hypertension. Moreover, although we
did not find a significant change in glycated hemoglobin levels, the point estimate of the
decrease we observed is consistent with that which would be expected on the basis of our
estimated increase in the use of medication for diabetes. The clinical-trial literature indicates
that the use of oral medication for diabetes reduces the glycated hemoglobin level by an
average of 1 percentage point within as short a time as 6 months.15 This estimate from the
clinical literature suggests that the 5.4-percentage-point increase in the use of medication for
diabetes in our cohort would decrease the average glycated hemoglobin level in the study
population by 0.05 percentage points, which is well within our 95% confidence interval.
Beyond issues of power, the effects of Medicaid coverage may be limited by the multiple
sources of slippage in the connection between insurance coverage and observable
improvements in our health metrics; these potential sources of slippage include access to
care, diagnosis of underlying conditions, prescription of appropriate medications,
compliance with recommendations, and effectiveness of treatment in improving health.17
Anticipating limitations in statistical power, we prespecified analyses of subgroups in which
effects might be stronger, including the near-elderly and persons who reported having
received a diagnosis of diabetes, hypertension, a high cholesterol level, a heart attack, or
congestive heart failure before the lottery. We did not find significant changes in any of
these subgroups. To try to improve statistical power, we used the Framingham risk score as
a summary measure. This allowed us to reject a decrease of more than 20% in the predicted
10-year cardiovascular risk or a decrease of more than 10% in predicted risk among the
participants with high-risk diagnoses before the lottery. Our results were thus consistent with
at best limited improvements in these particular dimensions of physical health over this time
period, in contrast with the substantial improvement in mental health.
Although changes in health status are of great interest, they are not the only important
potential benefit of expanded health insurance coverage. Health insurance is a financial
product that is aimed at providing financial security by protecting people from catastrophic
health care expenses if they become injured or sick (and ensuring that the providers who see
them are paid). In our study, Medicaid coverage almost completely eliminated catastrophic
out-of-pocket medical expenditures.
Our estimates of the effect of Medicaid coverage on health, health care utilization, and
financial strain apply to able-bodied, uninsured adults with incomes below 100% of the
federal poverty level who express interest in insurance coverage — a population of
considerable interest for health care policy, given the planned expansion of Medicaid. The
Patient Protection and Affordable Care Act of 2010 allows states to extend Medicaid
eligibility to all adults with incomes of up to 138% of the federal poverty level. However,
there are several important limits to the generalizability of our findings. First, the low-
income uninsured population in Oregon differs from the overall population in the United
States in some respects, such as the proportions of persons who are members of racial and
ethnic minority groups. Second, our estimates speak to the effect of Medicaid coverage on
the subgroup of people who signed up for the lottery and for whom winning the lottery
affected their coverage status; in the Supplementary Appendix we provide some additional
details on the characteristics of this group. Medicaid coverage may have different effects for
persons who seek insurance through the lottery than for the general population affected by
coverage mandates. For example, persons who signed up for the lottery may have expected a
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greater health benefit from insurance coverage than those who did not sign up. Of course,
most estimates suggest imperfect (and selective) Medicaid take-up rates even under
mandates.18 Third, the newly insured participants in our study constituted a small share of
all uninsured Oregon residents, limiting the system-level effects that insuring them might
generate, such as strains on provider capacity or investment in infrastructure. Fourth, we
examined outcomes in people who gained an average of 17 months of coverage (those
insured through the lottery were not necessarily covered for the entire study period); the
effects of insurance in the longer run may differ.
Despite these limitations, our study provides evidence of the effects of expanding Medicaid
to low-income adults on the basis of a randomized design, which is rarely available in the
evaluation of social insurance programs. We found that insurance led to increased access to
and utilization of health care, substantial improvements in mental health, and reductions in
financial strain, but we did not observe reductions in measured blood-pressure, cholesterol,
or glycated hemoglobin levels.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Table 1
Characteristics of the 12,229 Survey Respondents.*
Characteristic Controls (N = 5842) Lottery Winners (N = 6387)† P Value
percent
Female sex 56.9 56.4 0.60
Age group‡
 19–34 yr 36.0 35.1 0.38
 35–49 yr 36.4 36.6 0.87
 50–64 yr 27.6 28.3 0.43
Race or ethnic group§
 Non-Hispanic
  White 68.8 69.2 0.68
  Black 10.5 10.6 0.82
  Other 14.8 14.8 0.97
 Hispanic 17.2 17.0 0.82
Interview conducted in English 88.2 88.5 0.74
*Values for the control group (persons not selected in the lottery) are weighted means, and values for the lottery-winner group are regression-
adjusted weighted means. P values are for two-tailed t-tests of the equality of the two means.
†
Lottery winners were adults who were randomly selected in the lottery to be able to apply for Medicaid coverage.
‡
The data on age are for the age of the respondent at the time of the in-person interview. The study sample was restricted to persons who were
between 19 and 64 years of age during the study period.
§
Race and ethnic group were self-reported. The categories of non-Hispanic race (white, black, and other) were not mutually exclusive; respondents
could report as many races or ethnic groups as they wished.
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Table 2
Mean Values and Absolute Change in Clinical Measures and Health Outcomes with Medicaid Coverage.*
Variable
Mean Value in
Control Group
Change with Medicaid Coverage (95%
CI)† P Value
Blood pressure
 Systolic (mm Hg) 119.3±16.9 −0.52 (−2.97 to 1.93) 0.68
 Diastolic (mm Hg) 76.0±12.1 −0.81 (−2.65 to 1.04) 0.39
 Elevated (%)‡ 16.3 −1.33 (−7.16 to 4.49) 0.65
Hypertension
 Diagnosis after lottery (%)§¶ 5.6 1.76 (−1.89 to 5.40) 0.34
 Current use of medication for hypertension (%)§|| 13.9 0.66 (−4.48 to 5.80) 0.80
Cholesterol**
 Total level (mg/dl) 204.1±34.0 2.20 (−3.44 to 7.84) 0.45
 High total level (%) 14.1 −2.43 (−7.75 to 2.89) 0.37
 HDL level (mg/dl) 47.6±13.1 0.83 (−1.31 to 2.98) 0.45
 Low HDL level (%) 28.0 −2.82 (−10.28 to 4.64) 0.46
Hypercholesterolemia
 Diagnosis after lottery (%)§¶ 6.1 2.39 (−1.52 to 6.29) 0.23
 Current use of medication for high cholesterol level
(%)§||
8.5 3.80 (−0.75 to 8.35) 0.10
Glycated hemoglobin
 Level (%) 5.3±0.6 0.01 (−0.09 to 0.11) 0.82
 Level ≥6.5% (%)†† 5.1 −0.93 (−4.44 to 2.59) 0.61
Diabetes
 Diagnosis after lottery (%)§¶ 1.1 3.83 (1.93 to 5.73) <0.001
 Current use of medication for diabetes (%)§|| 6.4 5.43 (1.39 to 9.48) 0.008
Depression
 Positive screening result (%)‡‡ 30.0 −9.15 (−16.70 to −1.60) 0.02
 Diagnosis after lottery (%)§¶ 4.8 3.81 (0.15 to 7.46) 0.04
 Current use of medication for depression (%)§|| 16.8 5.49 (−0.46 to 11.45) 0.07
Framingham risk score (%)§§
 Overall 8.2±7.5 −0.21 (−1.56 to 1.15) 0.76
 High-risk diagnosis 11.6±8.3 1.63 (−1.11 to 4.37) 0.24
 Age of 50–64 yr 13.9±8.2 −0.37 (−2.64 to 1.90) 0.75
*
Plus–minus values are weighted means ±SD. Where means are shown without standard deviations, they are weighted means. The effect of
Medicaid coverage was estimated with the use of two-stage least-squares instrumental-variable regression. All regressions include indicators for
the number of household members on the lottery list, and all standard errors were “clustered,” or adjusted to allow for arbitrary correction of error
terms within households. For the blood-pressure measures, all regressions also included controls for age (with dummies for age decile) and sex. All
analyses were weighted with the use of survey weights. The sample size was all 12,229 survey respondents for all measures except for the
Framingham risk score. HDL denotes high-density lipoprotein.
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†
For variables measured as percentages, the change is expressed as percentage points.
‡
Elevated blood pressure was defined as a systolic pressure of 140 mm Hg or more and a diastolic pressure of 90 mm Hg or more.
§
This analysis was not prespecified.
¶A participant was considered to have received a diagnosis of a certain condition after the lottery if he or she reported a first diagnosis after March
2008 (the start of the lottery). A participant who received a diagnosis before March 2008 was not considered to have a diagnosis after the lottery.
||A participant was considered to have received medication for the condition if one or more of the medications recorded during the interview was
classified as relevant for that condition.
**A high total cholesterol level was defined as 240 mg per deciliter (6.2 mmol per liter) or higher. A low HDL cholesterol level was defined as less
than 40 mg per deciliter (1.03 mmol per liter). There was no separate measurement of low-density lipoprotein cholesterol.
††A glycated hemoglobin level of 6.5% or higher is a diagnostic criterion for diabetes.
‡‡A positive result on screening for depression was defined as a score of 10 or higher on the Patient Health Questionnaire 8 (PHQ-8). Scores on
the PHQ-8 range from 0 to 24, with higher scores indicating more symptoms of depression.
§§
The Framingham risk score was used to predict the 10-year cardiovascular risk. Risk scores were calculated separately for men and women on
the basis of the following variables: age, total cholesterol and HDL cholesterol levels, measured blood pressure and use or nonuse of medication for
high blood pressure, current smoking status, and status with respect to a glycated hemoglobin level ≥6.5%. Framingham risk scores, which are
calculated for persons 30 years of age or older, range from 0.99 to 30%. Samples sizes for risk scores were 9525 participants overall, 3099
participants with high-risk diagnoses, and 3372 participants with an age of 50 to 64 years. A high-risk diagnosis was defined as a diagnosis of
diabetes, hypertension, hypercholesterolemia, myocardial infarction, or congestive heart failure before the lottery (i.e., before March 2008).
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Table 3
Mean Values and Absolute Change in Health-Related Quality of Life and Happiness with Medicaid
Coverage.*
Variable Mean Value in Control Group Change with Medicaid Coverage (95% CI)† P Value
Health-related quality of life
 Health same or better vs. 1 yr earlier (%) 80.4 7.84 (1.45 to 14.23) 0.02
 SF-8 subscale‡
  Mental-component score 44.4±11.4 1.95 (0.03 to 3.88) 0.05
  Physical-component score 45.5±10.5 1.20 (−0.54 to 2.93) 0.18
 No pain or very mild pain (%) 56.4 1.16 (−6.94 to 9.26) 0.78
Very happy or pretty happy (%) 74.9 1.18 (−5.85 to 8.21) 0.74
*
Plus–minus values are weighted means ±SD. Where means are shown without standard deviations, they are weighted means. The effect of
Medicaid coverage was estimated with the use of two-stage least-squares instrumental-variable regression. All regressions included indicators for
the number of household members on the lottery list, and all standard errors were clustered on household. All analyses were weighted with the use
of survey weights. The sample was all 12,229 survey respondents.
†
For variables measured as percentages, the change is expressed as percentage points.
‡Scores on the Medical Outcomes Study 8-Item Short-Form Health Survey (SF-8) range from 0 to 100, with higher subscale scores indicating
better self-reported health-related quality of life. The scale is normalized to yield a mean of 50 and a standard deviation of 10 in the general U.S.
population.
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Table 4
Mean Values and Absolute Change in Financial Hardship with Medicaid Coverage.*
Variable
Mean Value in Control
Group
Change with Medicaid Coverage (95%
CI)† P Value
Any out-of-pocket spending (%) 58.8 −15.30 (−23.28 to −7.32) <0.001
Amount of out-of-pocket spending ($) 552.8±1219.5 −215.35 (−408.75 to −21.95) 0.03
Catastrophic expenditures (%)‡ 5.5 −4.48 (−8.26 to −0.69) 0.02
Any medical debt (%) 56.8 −13.28 (−21.59 to −4.96) 0.002
Borrowed money to pay bills or skipped payment (%) 24.4 −14.22 (−21.02 to −7.43) <0.001
*
Plus–minus values are weighted means ±SD. Where means are shown without standard deviations, they are weighted means. The effect of
Medicaid coverage was estimated with the use of two-stage least-squares instrumental-variable regression. All regressions include indicators for
the number of household members on the lottery list, and all standard errors were clustered on household. All analyses were weighted with the use
of survey weights. The sample was all 12,229 survey respondents.
†
For variables measured as percentages, the change is expressed as percentage points.
‡
Persons with catastrophic expenditures had out-of-pocket medical expenses that exceeded 30% of their household income.
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Table 5
Mean Values and Absolute Change in Health Care Utilization and Spending, Preventive Care, Access to and
Quality of Care, and Smoking and Obesity with Medicaid Coverage.*
Variable
Mean Value in Control
Group
Change with Medicaid Coverage (95% CI)
† P Value
Utilization (no. of visits or medications)
 Current prescription drugs 1.8±2.8 0.66 (0.21 to 1.11) 0.004
 Office visits in past 12 mo 5.5±11.6 2.70 (0.91 to 4.49) 0.003
 Outpatient surgery in past 12 mo 0.1±0.4 0.03 (−0.03 to 0.09) 0.28
 Emergency department visits in past 12 mo 1.0±2.0 0.09 (−0.23 to 0.42) 0.57
 Hospital admissions in past 12 mo 0.2±0.6 0.07 (−0.03 to 0.17) 0.17
 Estimate of annual health care spending ($)‡ 3,257.3 1,171.63 (199.35 to 2,143.91) 0.018
Preventive care in past 12 mo (%)
 Cholesterol-level screening 27.2 14.57 (7.09 to 22.04) <0.001
 Fecal occult-blood test in persons ≥50 yr 19.1 1.26 (−9.44 to 11.96) 0.82
 Colonoscopy in persons ≥50 yr 10.4 4.19 (−4.25 to 12.62) 0.33
 Flu shot in persons ≥50 yr 35.5 −5.74 (−19.31 to 7.83) 0.41
 Papanicolaou smear in women 44.9 14.44 (2.64 to 26.24) 0.016
 Mammography in women ≥50 yr 28.9 29.67 (11.96 to 47.37) 0.001
 PSA test in men ≥50 yr 21.4 19.18 (1.14 to 37.21) 0.037
Perceived access to and quality of care (%)
 Had a usual place of care 46.1 23.75 (15.44 to 32.06) <0.001
 Received all needed care in past 12 mo 61.0 11.43 (3.62 to 19.24) 0.004
 Care was of high quality, if received, in past 12 mo 78.4 9.85 (2.71 to 17.00) 0.007
Smoking status and obesity (%)
 Current smoker 42.8 5.58 (−2.54 to 13.70) 0.18
 Obese 41.5 0.39 (−7.89 to 8.67) 0.93
*
Plus–minus values are weighted means ±SD. Where means are shown without standard deviations, they are weighted means. The effect of
Medicaid coverage was estimated with the use of two-stage least-squares instrumental-variable regression. All regressions include indicators for
the number of household members on the lottery list, and all standard errors were clustered on household. All analyses were weighted with the use
of survey weights. The sample size was all 12,229 survey respondents. For some prevention measures, the sample was limited to the 3374 survey
respondents who were at least 50 years of age, the 1864 female survey respondents who were at least 50 years of age, or the 1509 male survey
respondents who were at least 50 years of age. The sample for quality of care was limited to the 9694 survey respondents who received care in the
previous 12 months. PSA denotes prostate-specific antigen.
†
For variables measured as percentages, the change is expressed as percentage points.
‡Annual spending was calculated by multiplying the numbers of prescription drugs, office visits, visits to the emergency department, and hospital
admissions by the estimated cost of each. See the Supplementary Appendix for details.
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